Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy

Journal of Experimental Medicine

Volumn 186, Issue 1, 1997, Pages 57-64

  Kishi, Shuji ^a   Saijyo, Shinobu ^b   Arai, Masaaki ^c   Karasawa, Shigeru ^d   Ueda, Susumu ^d   Kannagi, Mari ^c   Iwakura, Yoichiro ^b   Fujii, Masahiro ^c   Yonehara, Shin ^e  

^a Pharmaceutical Basic Res Labs J   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTHROPATHY; ARTICLE; AUTOIMMUNITY; CELL SURVIVAL; ETIOLOGY; FLOW CYTOMETRY; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JOINT DISEASES; JURKAT CELLS; MICE; MICE, TRANSGENIC; RETROVIRIDAE PROTEINS, ONCOGENIC; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0030834109     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.1.57     Document Type: Article

References (40)

1. Gianani, R., and N. Sarvetnick. 1996. Viruses, cytokines, antigens, and autoimmunity. Proc. Natl. Acad. Sci. USA. 93: 2257-2259.
2. Ridgway, W.M., H.L. Weiner, and C.G. Fathman. 1994. Regulation of autoimmune response. Curr. Opin. Immunol. 6: 946-955.
3. Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Rheumatoid arthritis. Cell. 85:307-310.
4. Franchini, G., and H. Streicher. 1995. Human T cell leukemia virus. Baillieres Clin. Haematol. 8:131-148.
5. Yoshida, M., T. Suzuki, J. Fujisawa, and H. Hirai. 1995. HTLV-1 oncoprotein tax and cellular transcription factors. Curr. Top. Microbiol. Immunol. 193:79-89.
6. Sugamura, K., and Y. Hinuma. 1993. Human Retroviruses: HTLV-I and HTLV-II. The retroviridae. Jay A. Levy, editor. Plenum Press, New York. 2:399-435.
7. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I-associated myelopathy, a new clinical entity. Lancet (N. Am. Ed.). i: 1031-1032.
8. Gessain, A., F. Barin, J.C. Vernant, O. Gout, L. Maurs, A. Calender, and d.T. G. 1985. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet (N. Am. Ed.). ii:407-409.
9. Nishioka, K., T. Nakajima, T. Hasunuma, and K. Sato. 1993. Rheumatic manifestation of human leukemia virus infection. Rheum. Dis.Clin. N. Am. 19:489-503.
10. Sodroski, J.G., C.A. Rosen, and W.A. Haseltine. 1984. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science (Wash. DC). 225:381-385.
11. x encoded by human T-cell leukemia virus type I. EMBO (Eur. Mol. Biol. Organ.) J. 5:2883-2888.
12. x and T3/Ti complex triggering. Cell. 48:343-350.
13. Cross, S.L., M.B. Feinberg, J.B. Wolf, N.J. Holbrook, F. Wong-Staal, and W.J. Leonard. 1987. Regulation of the human interleukin-2 receptor alpha chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 49:47-56.
14. Fujii, M., P. Sassone-Corsi, and I.M. Verma. 1988. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Prof. Natl. Acad. Sci. USA. 85:8526-8530.
15. tax protein in the human T-cell line. J. Virol. 68:3220-3226.
16. Kim, S.J., J.H. Kehrl, J. Burton, C.L. Tendler, K.T. Jeang, D. Danielpour, C. Thevenin, K.Y. Kim, M.B. Sporn, and A.B. Roberts. 1990. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-β1 in adult T cell leukemia. J. Exp. Med. 172: 121-129.
17. Fujii, M., T. Niki, T. Mori, T. Matsuda, M. Matsui, N. Nomura, and M. Seiki. 1991. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene. 6:1023-1029.
18. tax. Mol. Cell. Biol. 11:1313-1325.
19. Yamashita, I., S. Katamine, R. Moriuchi, Y. Nakamura, T. Miyamoto, K. Eguchi, and S. Nagataki. 1994. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood. 84:1573-1578.
20. Green, J.E., S.H. Hinrichs, J. Vogel, and G. Jay. 1989. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature (Lond.). 341:72-74.
21. Iwakura, Y., M. Tosu, E. Yoshida, M. Takiguchi, K. Sato, I. Kitajima, K. Nishioka, K. Yamamoto, T. Takeda, M. Hatanaka et al. 1991. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic tor HTLV-I. Science (Wash. DC). 253:1026-1028.
22. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
23. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
24. Nishimura, Y., A. Ishii, Y. Kobayashi, Y. Yamasaki, and S. Yonehara. 1995. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 154:4395-4403.
25. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature (Lond.). 349: 245-248.
26. Iwakura, Y., S. Saijo, Y. Kioka, J. Nakayama-Yamada, K. Itagaki, M. Tosu, M. Asano, Y. Kami, and K. Kakimoto. 1995. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 155:1588-1598.
27. Copeland, K.F., A.G. Haaksma, J. Goudsmit, P.H. Krammer, and J.L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses. 10:1259-1268.
28. Parijis, L.V., A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:321-328.
29. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-13.
30. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
31. Sytwu, H.-K., R.S. Liblau, and H.O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:17-30.
32. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Wash. DC). 274:782-784.
33. Wang, C.-Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis:potentiation by inhibition of NF-κB. Science (Wash. DC). 274:784-787.
34. Antwerp, D.J.V., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Wash. DC). 274:787-789.
35. Akagi, T., and K. Shimotohno. 1993. Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J. Virol. 67:1211-1217.
36. Keffer, J., L, Probert, H, Cazlaris, H., S. Georgopoulos, E. Kaslaris, E., D. Kioussis, D., and Kollias. 1991. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO (Eur. Mol. Biol. Organ.) J. 10:4025-4031.
37. Usuku, K., S. Sonoda, M. Osame, S. Yashiki, K. Takahashi, M. Matsumoto, T. Sawada, K. Tsuji, M. Tara, and A. Igata. 1988. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy:comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 23: S143-S150.
38. Osame, M., M. Matsumoto, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, M. Tara, and A. Igata. 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cells leukemia-like cells. Ann. Neurol. 21:117-122.
39. White, E., P. Sabbatini, M. Debbas, W.S. Wold, D.I. Kusher, and L.R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:2570-2580.
40. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90: 8479-8483.